Related content

IGF2 DMR0 Methylation, Loss of Imprinting, and Patient Prognosis in Esophageal Squamous Cell Carcinoma

By Murata Asuka   Baba Yoshifumi   Watanabe Masayuki   Shigaki Hironobu   Miyake Keisuke   Ishimoto Takatsugu   Iwatsuki Masaaki   Iwagami Shiro   Yoshida Naoya   Oki Eiji   Morita Masaru   Nakao Mitsuyoshi   Baba Hideo  

Annals of Surgical Oncology, Vol. 21, Iss. 4, 2014-04 ,pp. : 1166-1174

Springer Publishing Company

Access to resources Recommend Favorite

JAK2 inhibitor blocks the inflammation and growth of esophageal squamous cell carcinoma in vitro through the JAK/STAT3 pathway

By  

Oncology Reports, Vol. 33, Iss. 1, 2015-01 ,pp. : 494-502

Spandidos Publications

Access to resources Recommend Favorite

Loss of imprinting of IGF2 correlates with hypomethylation of the H19 differentially methylated region in the tumor tissue of colorectal cancer patients

By              

Molecular Medicine Reports, Vol. 5, Iss. 6, 2012-01 ,pp. : 1536-1540

Spandidos Publications

Access to resources Recommend Favorite

Decreased expression and aberrant methylation of Gadd45G is associated with tumor progression and poor prognosis in esophageal squamous cell carcinoma

By Guo Wei   Zhu Tienian   Dong Zhiming   Cui Lei   Zhang Minghui   Kuang Gang  

Clinical and Experimental Metastasis, Vol. 30, Iss. 8, 2013-12 ,pp. : 977-992

Springer Publishing Company

Access to resources Recommend Favorite

KPNA2 is a promising biomarker candidate for esophageal squamous cell carcinoma and correlates with cell proliferation

By    

Oncology Reports, Vol. 32, Iss. 4, 2014-01 ,pp. : 1631-1637

Spandidos Publications

Access to resources Recommend Favorite